Deno Medical is a professional innovative life sciences technology industry investment, incubation, and operation enterprise, headquartered in Hangzhou, with R&D centers in China and the United States. Deno Medical discovers, invests in, and integrates medical projects with disruptive innovative technologies globally, committed to seeking effective treatment solutions for major diseases that seriously threaten human health but currently lack effective means.
Deno Medical has a strong international medical advisory team (composed of renowned clinical doctors and industry experts both domestically and internationally). Leveraging rich industry experience, it adopts a dual-track model of independent innovation and introduction, digestion, absorption, and re-innovation to achieve the localization and industrialization of global innovative medical technologies in China.
Deno Medical possesses affiliated professional venture capital funds, utilizing capital, resources, and industry experience to incubate early-stage domestic innovative life sciences projects, accelerating their growth and industrialization. Meanwhile, it collaborates with venture capital funds to introduce foreign medical technology projects, achieving technology localization through digestion, absorption, and re-innovation. At present, it focuses on innovative diagnostic and therapeutic technologies including cardiovascular diseases, tumors, and diabetes.
Deno Medical adopts a corporatized management and operation model, with each project stationed in the form of a project company. In addition to providing project companies with GMP-compliant workshops, equipment and facilities, and property services, Deno Medical also offers a series of professional value-added services, including technical consultation, regulatory consultation, market information services, patent services, animal experiment platforms, clinical trials, medical device product registration, industrialization platforms, and market promotion.
By building a life sciences technology industry innovation incubation and acceleration platform that shares resources and services, Deno Medical fosters an open, integrated, and sustainable life sciences technology industry innovation ecosystem, creating multiple industrial and academic highlands in the domestic life sciences field, driving coordinated industrial development, enhancing the academic status and international influence of domestic medical research institutions in related fields, and contributing to the development of China's life sciences technology industry.
Deno Medical has established itself as an innovative platform capable of incubating internationally cutting-edge medical technology projects. It currently owns multiple projects including early lung cancer diagnostic and therapeutic devices (Broncus), peripheral vascular intervention devices (Vesselle Medical), structural heart disease intervention devices (Nuomao Medical), and heart valve repair devices (Dejin Medical).
Deno Medical's Hangzhou incubator possesses a production base exceeding 12,000 square meters in Binjiang District, Hangzhou, used for the production and operation of incubated projects.
What does Tianzhiwei Medical Technology (Shanghai) Co., Ltd. require? Who is Tianzhiwei Medical hiring? Tianzhiwei Medical recruitment: 销售类占比最多占36.4%，其次是计算机/网络/技术类占27.3%. What education can get in at Tianzhiwei Medical? 本科占比最多占63.6%，其次是硕士占27.3%. High education required at Tianzhiwei Medical? 硕士占27.3%. Work experience required at Tianzhiwei Medical? 3-5年占比最多占31.8%，其次是不限占31.8%. Where are the job locations at Tianzhiwei Medical? 深圳占比最多占45.5%，其次是上海占18.2%. Based on job postings from the past year, for reference only.
Provided by
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows
Jobui does not provide an APP. Please follow our WeChat official account.
